# Shingles Vaccine Linked to 51% Lower Dementia Risk in Major Study of 329,000 Adults

*2026-02-22 05:02 UTC · Science · 1 min read*

> Shingrix vaccine showed 51% lower dementia risk in 329,000-person study; expert panel ranks it top Alzheimer's repurposing candidate.

A large-scale study published in Nature Communications found that adults aged 65 and older who received the recombinant shingles vaccine (Shingrix) had a 51% lower observed risk of dementia compared to unvaccinated peers. Researchers at Kaiser Permanente Southern California tracked 65,800 vaccinated individuals against 263,200 matched controls over an average of 3.4 years, finding dementia incidence of 10.74 per 1,000 person-years in the vaccinated group versus 23.04 in the unvaccinated group.

The protective effect was stronger in women (55% reduction) than men (45% reduction). Separately, a University of Exeter panel of 21 dementia specialists reviewed 80 existing drugs and ranked the shingles vaccine as the top candidate for repurposing against Alzheimer's, ahead of sildenafil (Viagra) and riluzole. With one in three people born today expected to develop dementia, drug repurposing could bypass the typical 10-15 year development timeline.

## Sources

- [nature.com](https://www.nature.com/articles/s41467-026-69289-0)
- [sciencedaily.com](https://www.sciencedaily.com/releases/2026/02/260217005759.htm)

---
TechTools News · https://techtools.cz/tools/news/article/331-shingles-vaccine-linked-to-51-lower-dementia-risk-in-major-study-of-329-000
Česká verze: https://techtools.cz/tools/news/clanek/317-vakcina-proti-pasovemu-oparu-snizuje-riziko-demence-o-51-podle-velke-studie-329
